investor conferences

(NASDAQ:KGEI) THOUSAND OAKS, Calif.--(BUSINESS WIRE)--Kolibri Global Energy Inc. (the “Company” or “Kolibri”) (TSX: KEI, NASDAQ: KGEI) is providing an update on upcoming Investor Conferences and the Company’s Normal Course Issuer Bid. SIDOTI VIRTUAL INVESTOR CONFERENCE Mr. Regener will present and host one-on-one meetings with investors at the Sidoti September Virtual Investor Conference, scheduled to take place on September 17-18, 2025. The presentation will begin at 3:15 PM Eastern Time on September 18th,

IO Biotech Announces Participation in Upcoming Investor Conferences

(NASDAQ:CDTX) SAN DIEGO, Sept. 04, 2025 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company using its proprietary Cloudbreak® platform to develop drug-Fc conjugate (DFC) therapeutics, today announced that company management will participate in the below September investor conferences.

(NASDAQ:VTVT) HIGH POINT, N.C., Sept. 03, 2025 (GLOBE NEWSWIRE) -- vTv Therapeutics Inc. (Nasdaq: VTVT), a late-stage biopharmaceutical company focused on the development of cadisegliatin, a novel, potential first-in-class oral adjunctive therapy to insulin being investigated for the treatment of type 1 diabetes (T1D), today announced that management will participate in the following September investor conferences:

(NYSE:PRIM) DALLAS--(BUSINESS WIRE)--Primoris Services Corporation (NYSE: PRIM) (“Primoris” or “the Company”) announced today that the Company’s management team will participate in two upcoming institutional investor conferences. 12th Annual ROTH Solar & Storage Symposium at RE+ – Las Vegas, NV on September 9, 2025 D.A. Davidson 24th Annual Diversified Industrials & Services Conference – Nashville, TN on September 18, 2025 A copy of the Company’s most recent investor presentation will be available

374Water to Attend Upcoming Investor Conferences in September

(NASDAQ:COYA) HOUSTON, Sept. 3, 2025 /PRNewswire/ -- Coya Therapeutics, Inc. (NASDAQ: COYA) ("Coya" or the "Company"), a clinical-stage biotechnology company focused on developing biologics that enhance regulatory T cell (Treg) function in patients with neurodegenerative disorders, announces the...

(NYSE:HP) TULSA, Okla.--(BUSINESS WIRE)--Helmerich & Payne, Inc. (NYSE: HP) today announced that John Lindsay, President and Chief Executive Officer; Kevin Vann, Senior Vice President and Chief Financial Officer; and Todd Scruggs, Vice President of Finance & Treasury plan to participate in the following investor conferences during the month of September 2025. Participation by the management team will vary by event. The Barclays 39th Annual Energy-Power Conference on Tuesday and Wednesday, Septemb

(MOG) EAST AURORA, N.Y.--(BUSINESS WIRE)--Moog Inc. to Participate in Upcoming Investor Conferences

(NASDAQ:ETNB) SAN FRANCISCO, Aug. 28, 2025 (GLOBE NEWSWIRE) -- 89bio, Inc. (Nasdaq: ETNB), a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of liver and cardiometabolic diseases, today announced that the Company’s management will participate in the following investor conferences during the month of September:

DENVER--(BUSINESS WIRE)--Voyager Technologies, Inc. [NYSE: VOYG], a leading space, defense and national security company enabling mission-critical solutions across domains, is participating in the following upcoming conferences: Jefferies Industrials Conference, Sept. 3-4, New York – Management will present and participate in investor meetings. Morgan Stanley 13th Annual Laguna Conference, Sept. 12, Laguna Beach, Calif. – Management will present and participate in investor meetings. About Voyag

SOUTH SAN FRANCISCO, Calif., Aug. 27, 2025 (GLOBE NEWSWIRE) -- RAPT Therapeutics, Inc. (Nasdaq: RAPT), a clinical-stage immunology-based biopharmaceutical company focused on discovering, developing and commercializing novel therapies for patients living with inflammatory and immunological diseases, today announced that members of the RAPT management team will participate in the following investor conferences in September:

BOSTON & MONTREAL--(BUSINESS WIRE)--enGene Holdings Inc. (Nasdaq: ENGN or “enGene”), a clinical-stage, non-viral gene therapy company, today announced that management will participate in the following investor conferences in September: 2025 Wells Fargo Healthcare Conference Date: Wednesday, September 3, 2025 Time: 8:45 a.m. ET H.C. Wainwright 27th Annual Global Investment Conference Date: Monday, September 8, 2025 Time: 1:30 p.m. ET Morgan Stanley 23rd Annual Global Healthcare Conference Date:

HANOVER, Pa.--(BUSINESS WIRE)--Utz Brands, Inc. (NYSE: UTZ) (“Utz” or the “Company”), a leading U.S. manufacturer of branded Salty Snacks and a small-cap growth and value Staples equity, announced today that the Company plans to participate in the following investor conferences in September. Barclays Global Consumer Staples Conference September 3, 2025 At 2:15 p.m. EDT the Company will host a fireside chat with Barclays analyst Andrew Lazar, and participate in one-on-one and small group meeting

BRISBANE, Calif., Aug. 26, 2025 (GLOBE NEWSWIRE) -- Vera Therapeutics, Inc. (Nasdaq: VERA), a late clinical-stage biotechnology company focused on developing and commercializing transformative treatments for patients with serious immunological diseases, today announced that the Company’s management team will present and participate in one-on-one meetings at upcoming investor conferences.

NEWTON, Mass., Aug. 26, 2025 (GLOBE NEWSWIRE) -- Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS), a clinical-stage biopharmaceutical company developing novel therapeutics that target toxic soluble amyloid beta oligomers for the treatment of Alzheimer’s disease, announced today that management will participate in the following upcoming investor conferences.

OKLAHOMA CITY--(BUSINESS WIRE)--LSB Industries, Inc. (“LSB”), (NYSE: LXU), today announced that its Chairman & Chief Executive Officer, Mark Behrman will be participating in the following conferences: Jefferies Industrials Conference on Wednesday, September 3rd in New York City UBS Global Materials Conference on Thursday, September 4th in New York City Mr. Behrman will be conducting a “fireside chat” discussion at the Jefferies conference, which will be webcast and available for replay on t

WARREN, N.J., Aug. 26, 2025 (GLOBE NEWSWIRE) -- Aquestive Therapeutics, Inc. (NASDAQ: AQST) (“Aquestive” or the “Company”), a pharmaceutical company advancing medicines to bring meaningful improvement to patients' lives through innovative science and delivery technologies, announced today that the management team will participate in three upcoming investor conferences in September 2025 as follows:

NEW YORK, Aug. 26, 2025 (GLOBE NEWSWIRE) -- Syndax Pharmaceuticals (Nasdaq: SNDX), a commercial-stage biopharmaceutical company advancing innovative cancer therapies, today announced that Michael A. Metzger, Chief Executive Officer, as well as members of the Syndax management team, will participate in the following upcoming investor conferences:

BRENTWOOD, Tenn.--(BUSINESS WIRE)--Ardent Health to participate in September investor conferences